Skip to main content

Advertisement

Log in

High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates

  • Original article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Diode laser systems at 980 nm have been introduced for the treatment of lower-urinary-tract-symptoms (LUTS) suggestive of benign prostatic enlargement (BPE). However, the coagulation and vaporization properties are unknown. We therefore aimed to evaluate these properties in ex vivo models in comparison with the kalium-titanyl-phosphate-(KTP) laser. The diode laser treatment was applied to isolated, blood-perfused porcine kidneys and fresh human cadaver prostates (HCPs) at different generator settings. We performed histological examination to compare the depth of coagulation and vaporization. The diode laser showed larger ablation and coagulation characteristics than the KTP laser did. Ablation of the diode laser was found to be 1.79-times (120 W in porcine kidney, P < 0.0001) and 3.0–5 times (200 W in HCP, P < 0.0005) larger. The diode laser created a nine-times (120 W in porcine kidney, P < 0.0001) and seven-times (200 W in HCP, P < 0.0001) deeper necrosis zone. The diode laser vaporization was highly effective ex vivo. Owing to the laser’s deep coagulation zones, in vivo animal experiments are mandatory before the diode laser (980 nm) is applied in a clinical setting, so that damage to underlying structures is prevented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Costello AJ, Bowsher WG, Bolton DM, Braslis KG, Burt J (1992) Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 69:603–608

    Article  PubMed  CAS  Google Scholar 

  2. Malek RS, Barrett DM, Kuntzman RS (1998) High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 51:254–256

    Article  PubMed  CAS  Google Scholar 

  3. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS (2004) Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 172:1404–1408

    Article  PubMed  Google Scholar 

  4. Seitz M, Sroka R, Gratzke C, Schlenker B, Steinbrecher V, Khoder W, Tilki D, Bachmann A, Stief C, Reich O (2007) The diode laser: a novel side-firing approach for laser vaporisation of the human prostate—immediate efficacy and 1-year follow-up. Eur Urol 52:1717–1722

    Article  PubMed  Google Scholar 

  5. Seitz M, Ackermann A, Gratzke C, Schlenker B, Ruszat R, Bachmann A, Stief C, Reich O, Sroka R (2007) Diode laser: ex vivo studies on vaporization and coagulation characteristics. Urologe A 46:1242–1247

    Article  PubMed  CAS  Google Scholar 

  6. Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, Häcker A (2007) 980-nm Diode laser: a novel laser technology for vaporization of the prostate. Eur Urol 52:1723–1728

    Article  PubMed  Google Scholar 

  7. Kohrmann KU, Back W, Bensemann J, Florian J, Weber A, Kahmann F, Rassweiler J, Alken P (1994) The isolated perfused kidney of the pig: new model to evaluate shock wave-induced lesions. J Endourol 8:105–110

    PubMed  CAS  Google Scholar 

  8. Michel MS, Kohrmann KU, Weber A, Krautschick AW, Alken P (1996) Rotoresect. new technique for resection of the prostate: experimental phase. J Endourol 10:473–478

    Article  PubMed  CAS  Google Scholar 

  9. Reich O, Schneede P, Corvin S, Zaak D, Sroka R, Hofstetter A (2003) Combination of interstitial laser coagulation and transurethral resection of the prostate: ex vivo evaluations. Urology 61:1172–1176

    Article  PubMed  Google Scholar 

  10. Cooper TE, Trezek GJ (1972) A probe technique for determining the thermal conductivity of tissue. J Heat Transf 94:133

    Google Scholar 

  11. Reich O, Corvin S, Oberneder R, Sroka R, Muschter R, Hofstetter A (2002) In vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP), and vaporization-resection of the prostate (TUVRP). Urol Res 30:15–20

    Article  PubMed  Google Scholar 

  12. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554

    Article  PubMed  Google Scholar 

  13. Kaplan SA (2004) AUA guidelines and their impact on the management of BPH: an update. Rev Urol 6 [Suppl 9]:S46–S52

    Google Scholar 

  14. Reich O, Seitz M, Gratzke C, Schlenker B, Bachmann A, Stief C (2006) Benign prostatic syndrome (BPS). Ablative treatments. Urologe A 45:769–780; quiz 781–762

    Article  PubMed  CAS  Google Scholar 

  15. Gilling PJ, Fraundorfer MR (1998) Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 8:11–15

    Article  PubMed  CAS  Google Scholar 

  16. Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A (2004) Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 171:2502–2504

    Article  PubMed  Google Scholar 

  17. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T (2005) High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173:158–160

    Article  PubMed  Google Scholar 

  18. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE (2005) Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 19:1196–1198

    Article  PubMed  Google Scholar 

  19. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, Lehmann K, Sulser T (2005) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48:965–971

    Article  PubMed  Google Scholar 

  20. Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, Westenberg AM, Fraundorfer MR (2006) A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 50:569–573

    Article  PubMed  Google Scholar 

  21. Elzayat EA, Habib EI, Elhilali MM (2005) Holmium laser enucleation of the prostate: a size-independent new “gold standard". Urology 66:108–113

    Article  PubMed  Google Scholar 

  22. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97:1229–1233

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

The authors received no funding and no grants.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Seitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seitz, M., Reich, O., Gratzke, C. et al. High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates. Lasers Med Sci 24, 172–178 (2009). https://doi.org/10.1007/s10103-008-0543-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-008-0543-5

Keywords

Navigation